Title : Regorafenib-Attenuated, Bleomycin-Induced Pulmonary Fibrosis by Inhibiting the TGF-β1 Signaling Pathway.

Pub. Date : 2021 Feb 17

PMID : 33671452






4 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Regorafenib-Attenuated, Bleomycin-Induced Pulmonary Fibrosis by Inhibiting the TGF-beta1 Signaling Pathway. regorafenib transforming growth factor beta 1 Homo sapiens
2 Further in vitro mechanism studies showed that regorafenib inhibits the activation and migration of myofibroblasts and extracellular matrix production, mainly through suppressing the transforming growth factor (TGF)-beta1/Smad and non-Smad signaling pathways. regorafenib transforming growth factor beta 1 Homo sapiens
3 In vitro studies have also indicated that regorafenib could augment autophagy in myofibroblasts by suppressing TGF-beta1/mTOR (mechanistic target of rapamycin) signaling, and could promote apoptosis in myofibroblasts. regorafenib transforming growth factor beta 1 Homo sapiens
4 In conclusion, regorafenib attenuates bleomycin-induced pulmonary fibrosis by suppressing the TGF-beta1 signaling pathway. regorafenib transforming growth factor beta 1 Homo sapiens